BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 20459770)

  • 1. Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas.
    Van Damme N; Deron P; Van Roy N; Demetter P; Bols A; Van Dorpe J; Baert F; Van Laethem JL; Speleman F; Pauwels P; Peeters M
    BMC Cancer; 2010 May; 10():189. PubMed ID: 20459770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EGFR and K-ras gene mutation status in squamous cell anal carcinoma: a role for concurrent radiation and EGFR inhibitors?
    Paliga A; Onerheim R; Gologan A; Chong G; Spatz A; Niazi T; Garant A; Macheto D; Alcindor T; Vuong T
    Br J Cancer; 2012 Nov; 107(11):1864-8. PubMed ID: 23093229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for EGFR and KRAS mutations in non-small cell lung carcinomas using DNA extraction by hydrothermal pressure coupled with PCR-based direct sequencing.
    Liu Y; Wu BQ; Zhong HH; Hui P; Fang WG
    Int J Clin Exp Pathol; 2013; 6(9):1880-9. PubMed ID: 24040454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular profiles of EGFR, K-ras, c-met, and FGFR in pulmonary pleomorphic carcinoma, a rare lung malignancy.
    Lee S; Kim Y; Sun JM; Choi YL; Kim JG; Shim YM; Park YH; Ahn JS; Park K; Han JH; Ahn MJ
    J Cancer Res Clin Oncol; 2011 Aug; 137(8):1203-11. PubMed ID: 21626008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of epidermal growth factor receptor in squamous cell carcinomas of the anal canal is independent of gene amplification.
    Alvarez G; Perry A; Tan BR; Wang HL
    Mod Pathol; 2006 Jul; 19(7):942-9. PubMed ID: 16648870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between EGFR and K-ras mutations and clinicopathological characteristics and response to erlotinib treatment in 301 Chinese patients with non-small cell lung cancer].
    Sun LN; Luan HL; Zang FL; Wang M; Dong N; Guo Y; Sun BC; Zhan ZL
    Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):667-70. PubMed ID: 21122380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. K-ras status in squamous cell anal carcinoma (SCC): it's time for target-oriented treatment?
    Zampino MG; Magni E; Sonzogni A; Renne G
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):197-9. PubMed ID: 19727729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in epidermal growth factor receptors 1 and 2 in esophageal squamous cell carcinomas.
    Gonzaga IM; Soares-Lima SC; de Santos PT; Blanco TC; de Reis BS; Quintella DC; de Oliveira IM; de Faria PA; Kruel CD; Andreollo NA; de Simão TA; Pinto LF
    BMC Cancer; 2012 Dec; 12():569. PubMed ID: 23207070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC.
    Kalikaki A; Koutsopoulos A; Trypaki M; Souglakos J; Stathopoulos E; Georgoulias V; Mavroudis D; Voutsina A
    Br J Cancer; 2008 Sep; 99(6):923-9. PubMed ID: 19238633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p16INK4A, p53, EGFR expression and KRAS mutation status in squamous cell cancers of the anus: correlation with outcomes following chemo-radiotherapy.
    Gilbert DC; Williams A; Allan K; Stokoe J; Jackson T; Linsdall S; Bailey CM; Summers J
    Radiother Oncol; 2013 Oct; 109(1):146-51. PubMed ID: 24021343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFR, KRAS, BRAF, and PIK3CA characterization in squamous cell anal cancer.
    Martin V; Zanellato E; Franzetti-Pellanda A; Molinari F; Movilia A; Paganotti A; Deantonio L; De Dosso S; Assi A; Crippa S; Boldorini R; Mazzucchelli L; Saletti P; Frattini M
    Histol Histopathol; 2014 Apr; 29(4):513-21. PubMed ID: 24122611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGFR and KRAS mutations in Turkish non-small cell lung cancer patients: a pilot study.
    Bircan S; Baloglu H; Kucukodaci Z; Bircan A
    Med Oncol; 2014 Aug; 31(8):87. PubMed ID: 24973952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KRAS and BRAF mutations in anal carcinoma.
    Serup-Hansen E; Linnemann D; Høgdall E; Geertsen PF; Havsteen H
    APMIS; 2015 Jan; 123(1):53-9. PubMed ID: 25244542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High resolution melting analysis for rapid and sensitive EGFR and KRAS mutation detection in formalin fixed paraffin embedded biopsies.
    Do H; Krypuy M; Mitchell PL; Fox SB; Dobrovic A
    BMC Cancer; 2008 May; 8():142. PubMed ID: 18495026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MET gene copy number in non-small cell lung cancer: molecular analysis in a targeted tyrosine kinase inhibitor naïve cohort.
    Beau-Faller M; Ruppert AM; Voegeli AC; Neuville A; Meyer N; Guerin E; Legrain M; Mennecier B; Wihlm JM; Massard G; Quoix E; Oudet P; Gaub MP
    J Thorac Oncol; 2008 Apr; 3(4):331-9. PubMed ID: 18379349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of EGFR and K-ras mutations in fixed and fresh specimens from transesophageal ultrasound-guided fine needle aspiration in non-small cell lung cancer patients.
    Ulivi P; Romagnoli M; Chiadini E; Casoni GL; Capelli L; Gurioli C; Zoli W; Saragoni L; Dubini A; Tesei A; Amadori D; Poletti V
    Int J Oncol; 2012 Jul; 41(1):147-52. PubMed ID: 22504767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of genetic alterations and expression of epidermal growth factor receptor (EGFR) in head and neck squamous cell carcinomas.
    Szabó B; Nelhubel GA; Kárpáti A; Kenessey I; Jóri B; Székely C; Peták I; Lotz G; Hegedus Z; Hegedus B; Füle T; Döme B; Tímár J; Tóvári J
    Oral Oncol; 2011 Jun; 47(6):487-96. PubMed ID: 21498106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copy number amplification of the PIK3CA gene is associated with poor prognosis in non-lymph node metastatic head and neck squamous cell carcinoma.
    Suda T; Hama T; Kondo S; Yuza Y; Yoshikawa M; Urashima M; Kato T; Moriyama H
    BMC Cancer; 2012 Sep; 12():416. PubMed ID: 22994622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KRAS, BRAF and PIK3CA status in squamous cell anal carcinoma (SCAC).
    Casadei Gardini A; Capelli L; Ulivi P; Giannini M; Freier E; Tamberi S; Scarpi E; Passardi A; Zoli W; Ragazzini A; Amadori D; Frassineti GL
    PLoS One; 2014; 9(3):e92071. PubMed ID: 24642661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.